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apeutic treatments. As a contribution to the improvement of drugs against several tropical diseases caused by
protozoa, we screened Portuguese propolis and its potential ﬂoral sources Populus x Canadensis and Cistus
ladanifer against Plasmodium falciparum, Leishmania infantum, Trypanosoma brucei and Trypanosoma cruzi.
The toxicity against MRC-5 ﬁbroblast cells was evaluated to assess selectivity. The in vitro assays were performed
following the recommendations of WHO Special Programme for Research and Training in Tropical Diseases
(TDR) and revealed moderate activity, with the propolis extracts presenting the relatively highest inhibitory
effect against T. brucei. Additionally, the antimicrobial activity against Staphylococcus aureus, Candida albicans,
Trichophyton rubrum and Aspergillus fumigatus was also veriﬁed with the better results observed against
T. rubrum. The quality of the extracts was controlled by evaluating the phenolic content and antioxidant activity.
The observed biological activity variations are associated with the variable chemical composition of the propolis
and the potential ﬂoral sources under study. Copyright © 2013 John Wiley & Sons, Ltd.
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Propolis is a resinous bee product collected by honey-
bees (Apis melifera L.) from parts of plants, buds and
exudates on the vegetation around the hive and
enriched with wax, salivary and enzymatic secretions
(Marcucci, 1995). This natural resinous substance plays
an important role as construction and defence material
against infections in the hive (Bankova et al., 2000)
and preserves some of the medicinal properties of certain
plants. For instance, Cistus species secrete large amounts
of a strong aromatic resin on the surface of leaves and
stems, rich in polyphenols and used since ancient times
to treat diarrhea, dysentery and menstruation problems
(Robles et al., 2003). The Populus bud exudates have
long been used in popular medicine for treating wounds
and ulcers. Their antiseptic, anti-inﬂammatory and anti-
microbial properties have been documented (Scaysbrook
et al., 1992; Zhang et al., 2006).
During the last decades, propolis has become the
subject of increased scientiﬁc interest for its wide variety
of pharmacological and biological properties, such as
antibacterial (Sforcin et al., 2000), antifungal (Millet-
Clerc et al., 1987), antiviral (Amoros et al., 1992),ondence to: Miguel Vilas-Boas, CIMO - Escola Superior Agrária,
litécnico de Bragança, Campus de Sta. Apolónia, Apartado 1172,
ragança, Portugal.
boas@ipb.pt
© 2013 John Wiley & Sons, Ltd.antiprotozoal (Monzote et al., 2012), antioxidant,
hepatoprotective, antitumor and anti-inﬂammatory
(Banskota et al., 2001) activities. Approximately half
of the propolis content corresponds to phenolic com-
pounds, while beeswax, volatiles and pollen account
for, respectively, 30%, 10% and 5% (Burdock, 1998).
The chemical composition of propolis is highly variable
and complex, depending strongly on the plant sources
available at the site of collection and thus on the
geographic and climatic characteristics of the apiary
location. In regions of temperate climate, bees obtain
resins from the buds of Populus spp., and derived prop-
olis is mainly composed by ﬂavonoids, phenolic acids
and their esters. In tropical areas, species of Baccharis
spp. in Brazil and Clusia spp. in Cuba and Venezuela
are the main sources of propolis, with prenylated
p-coumaric acids and polyisoprenylated benzophenones
as the main compounds in Baccharis and Clusia-derived
propolis, respectively (Bankova et al., 2000). Despite the
compositional differences between propolis types, their
biological properties are very similar, e.g. all possess
antimicrobial activity.
Propolis from North-eastern Portugal was recently
characterized, providing identiﬁcation of 37 phenolic
compounds, with pinocembrin, chrysin and pinobanksin-
3-O-acetate being the most abundant (Falcão et al.,
2010). The phenolic compounds show strong antioxidant
activity and decrease erythrocyte membrane fragility
in hereditary spherocytosis (Moreira et al., 2011). Prop-
olis extracts also strongly suppress the proliferation ofReceived 22 January 2013
Revised 18 April 2013
Accepted 4 May 2013
438 S.I. FALCÃO ET AL.primary renal cancer cells in a concentration-dependent
manner (Valente et al., 2011) and are able to exert moder-
ate neuroprotection through the inhibition of caspase-3
activation (Cardoso et al., 2011). Portuguese propolis
extracts were shown to have antimicrobial activity
against Staphylococcus aureus, Pseudomonas aeruginosa,
Escherichia coli and Candida albicans (Silva et al., 2012),
with the Gram-negative bacteria being more sensitive to
the bee glue. To the best of our knowledge, there are
yet no studies on the activity of Portuguese propolis
against pathogenic protozoa.
In this study, Portuguese propolis phenolic extracts and
their potential plant sources were screened in vitro for
their activity against the pathogenic protozoaPlasmodium
falciparum, Leishmania infantum, Trypanosoma cruzi
and Trypanosoma brucei. To assess selectivity of action,
cytotoxicity against MRC-5 ﬁbroblasts and antibacterial
and antifungal activities were evaluated in parallel. The
quality of the extracts was assessed by evaluating their
phenolic content and antioxidant activity.MATERIALS AND METHODS
Chemicals and reagents. Standard compounds such
as galangin, pinocembrin, caffeic acid, chloroquine,
melarsoprol, benznidazole, miltefosine, tamoxifen, as well
as other chemicals, such as aluminium chloride, potassium
ferricyanide, ferric chloride, trichloroacetic acid, 2,2-
diphenyl-1-picrylhydrazyl (DPPH) and dimethyl sulfoxide
(DMSO) were all purchased from Sigma Chemical Co
(St. Louis, MO, USA). Analytical grade reagents like so-
dium carbonate, potassium hydroxide, Folin–Ciocalteau
reagent, acetic acid, sulphuric acid, formic acid, ethanol
and methanol were obtained from Panreac (Barcelona,
Spain). 2,4-Dinitrophenylhydrazine (DNP), ampicillin
and miconazole were from Fluka Chemical Co (St. Louis,
MO, USA).Water was treated in aMilli-Q water puriﬁca-
tion system (TGI Pure Water Systems, USA).Samples origin and preparation. The study was per-
formed on propolis and plant samples present in the
hive neighborhood that were reported (Bankova et al.,
2000) as propolis ﬂoral sources. Two different propolis
samples were collected from beekeepers after the honey
harvesting season by scratching the hive walls and
frames, followed by the removal of debris of wood
and bees. Sample A1 was collected in North-eastern
Portugal (Bragança county), while sample A2 was col-
lected from the centre of Portugal (Leiria county). For
the ﬂoral sources of the bee glue, the buds exudates and
surface material present on the leaves and stems of
Populus x Canadensis Moenchen (an hybrid species of
Populus) male (PM) and female specimens (PF) and
Cistus ladanifer L. (C) were collected during spring. All
samples were stored at20 C until analysis. The voucher
specimens are deposited at the herbarium of Escola
Superior Agrária of Instituto Politécnico de Bragança
with the reference number BRESA 5174, BRESA 5355
and BRESA 5356 for C, PF and PM, respectively.
The extraction was made according to the work previ-
ously described (Falcão et al., 2010). Prior to the extrac-
tion, 1 g of powdered propolis sample was homogenizedCopyright © 2013 John Wiley & Sons, Ltd.and mixed with 10mL of 80% of ethanol/water and kept
at 70 C for 1 h. The resulting mixtures were ﬁltered, and
the residues were re-extracted in the same conditions.
After the second extraction, the ﬁltrates were combined,
concentrated and freeze-dried. For biological studies,
stock solutions of the extracts were prepared in 13%
DMSO/water (propolis) or 100% DMSO (ﬂoral sources)
at 20mg/mL.
Total phenolic content. The total phenolic content was
determined with a modiﬁed Folin–Ciocalteu method
(Singleton and Rossi, 1965). An ethanolic extract ali-
quot (0.5mL) was mixed with 0.25mL Folin–Ciocalteu’s
reagent. After 3min, 1mL of a saturated sodium car-
bonate solution was added to the mixture, and the vol-
ume adjusted to 5mL with distilled water. The solution
was then heated at 70 C for 10min, cooled in the dark
for 30min, and the optical density was measured at
760 nm (Analytikijena 200–2004 spectrophotometer,
Analytik Jena, Jena, Germany). The ethanolic extracts
were evaluated at the ﬁnal concentration of 0.05mg/L,
and the total phenolic content was expressed in milli-
grams per gram of caffeic acid:galangin:pinocembrin
(1:1:1) equivalents. For each extract, measurements
were performed in three independent experiments.
Flavone and ﬂavonol content. The content of ﬂavone
and ﬂavonol was determined based on the method previ-
ously described (Cvek et al., 2007) with minor modiﬁca-
tions. Brieﬂy, 2mL of the ethanolic extract was added
to 0.2mL of aluminium chloride solution (2% aluminium
chloride in 5% acetic acid/methanol), and the volume
was adjusted to 5mL with 5% acetic acid/methanol.
After 30min at room temperature, the optical density
wasmeasured at 415 nm. The ethanolic extracts were eval-
uated in triplicate at a ﬁnal concentration of 0.1mg/L,
and the ﬂavone and ﬂavonol contents were expressed as
milligrams per gram of galangin equivalents.
Flavanone and dihydroﬂavonol content. Flavanones and
dihydroﬂavonols were determined using a previously
described method (Popova et al., 2004). Brieﬂy, 1mL
of the test solution and 2mL of DNP solution (1 g of
DNP was dissolved in 2mL of 96% sulphuric acid and
the volume was adjusted to 100mL with methanol)
were heated at 50 C for 50min. After cooling to room
temperature, the mixture was diluted to 10mL with
10% potassium hydroxide in methanol (w/v). An ali-
quot (1mL) of the resulting solution was added to
10mL of methanol and diluted to 50mL with methanol.
Finally, the optical density was measured at 486nm.
The content in ﬂavanones and dihydroﬂavonols was eval-
uated in triplicate and expressed as milligrams per gram
of pinocembrin equivalents.
DPPH free radical-scavenging activity. The antioxidant
effect on DPPH radical was measured according to the
procedure described previously (Brand-Williams et al.,
1995) with some modiﬁcations. The reaction was per-
formed in a 96-well microplate where an aliquot of
propolis extract (0.08mL) in 80% ethanol containingPhytother. Res. 28: 437–443 (2014)
439ANTIPROTOZOAL ACTIVITY OF PORTUGUESE PROPOLIS AND ITS FLORAL SOURCESdifferent extract concentrations (2.5–40mg/mL)was added
to 0.220mL of DPPH (0.025 g/L in 80% ethanol, daily
prepared).After 45min at room temperature, optical den-
sity was measured at 515nm using an ELX800Microplate
Reader (Bio-Tek Instruments, Inc.). A mixture of pheno-
lic compounds (caffeic acid: galangin: pinocembrin; 1:1:1)
was used as standard. The percentage of radical inhibi-
tion was calculated from the absorbance of the DPPH
solution without sample (ADPPH) and of the DPPH solu-
tion with sample (Asample), using the following equation:
% Inhibition= [(ADPPH-Asample)/ADPPH] 100.
This percentage was plotted against the extract con-
centration to obtain the amount of antioxidant needed
to decrease the initial DPPH concentration by 50%
(EC50). The assay was performed in triplicate.
Reducing power. The reducing power of the propolis
extracts was determined according to the method of
Oyaizu (1986). 2.5mL of the propolis ethanolic extract
(10–200 mg/mL) was mixed with 2.5mL phosphate
buffer (0.2mol/L, pH 6.6) and 2.5mL of 1% potassium
ferricyanide. The mixture was incubated at 50 C for
20min. Then, 2.5mL of 10% trichloroacetic acid was
added to the mixture followed by centrifugation at
3000 rpm (Centurion K2R series) for 10min. The upper
layer of the solution (2.5mL) was mixed with distilled
water (2.5mL) and FeCl3 (0.5mL, 0.1%). Finally, the
optical density was measured at 700 nm. A mixture of
caffeic acid: galangin: pinocembrin (1:1:1) was used as
standard. An increase of the optical density for the reac-
tion mixture indicates a higher reducing power. The
complex with absorbance is the result of the phenolic
compound reaction during the reduction of iron. The assay
was run in triplicate in independent experiments.
Test plate production for antimicrobial evaluation. The
experiments were performed in 96-well plates (Greiner)
at four-fold dilutions in a dose-titration range of 64mg/mL
to 0.25 mg/mL. Dilutions were carried out by a pro-
grammable precision robotic station (BIOMEK 2000,
Beckman, USA). Each plate also contained medium-
controls (blanks: 0% growth), infected untreated con-
trols (negative control: 100% growth) and reference
controls (positive control). Tests were run in duplicate
in two independent experiments.
Biological screening tests. The integrated panel of mi-
crobial screens for the present study and the standard
screening methodologies were adopted as described
before (Cos et al., 2006). Extracts with high cytotoxicity
and/or non-selective activity against the different proto-
zoa were not titrated down to their exact IC50.
Antiplasmodial activity. The chloroquine-susceptible
P. falciparum GHA-strain was used. Parasites were cul-
tured in human erythrocytes A+ at 37 C under a low ox-
ygen atmosphere (3% O2, 4% CO2 and 93% N2) in a
modular incubation chamber (Trager and Jensen, 1976).
The culture medium was RPMI-1640 supplemented with
10% human serum. Two hundred microliters of infected
human red blood cells suspension (1% parasitemia, 2%Copyright © 2013 John Wiley & Sons, Ltd.hematocrit) were added to each well of the plates with
test compounds and incubated for 72 h. After incubation,
test plates were frozen at 20 C. Parasite multiplication
was measured by the Malstat method (Makler et al.,
1993). One hundred microliters of Malstat reagent was
transferred in a new plate and mixed with 20 mL of the
hemolysed parasite suspension for 15min at room tem-
perature. After addition of 20 mL nitroblue tetrazolium
(NBT)/phenazine ethosulphate (PES) solution (1.6mg
of NBT and 0.1mg of PES) and 2h incubation in the
dark, the optical density was spectrophotometrically read
at 655nm (Biorad 3550-UV microplate reader). Percent-
age of growth inhibition was compared to the negative
blanks. Chloroquine was used as reference drug.Antitrypanosomal activity. Trypomastigotes of T. brucei
Squib-427 strain (suramin-sensitive) were cultured at
37 C and 5% CO2 in Hirumi-9 medium (Hirumi and
Hirumi, 1989), supplemented with 10% fetal calf serum
(FCS). Assays were performed by adding 1.5 104
trypomastigotes/well. After 72h incubation, parasite
growth was assessed ﬂuorimetrically by adding resazurin
(Raz et al., 1997) for 24 h at 37 C. Fluorescence was
measured using a GENios Tecan ﬂuorimeter (excitation
530nm, emission 590nm). Melarsoprol was used as
reference drug.
Amastigotes of T. cruzi (Tulahuen CL2 strain,
nifurtimox-sensitive) were maintained on MRC-5 cells
in minimal essential medium (MEM) supplemented
with 20mML-glutamine, 16.5mM sodium hydrogen
carbonate and 5% FCS at 37 C and 5% CO2. To deter-
mine in vitro activity, 4 103 MRC-5 cells and 4 104
parasites were added to each well of the test plate with
compound. After incubation at 37 C for 7 days, parasite
growth was assessed by adding b-galactosidase sub-
strate chlorophenol red b-D-galactopyranoside (Buckner
et al., 1996) for 4 h at 37 C. The colour reaction was read
at 540 nm, and optical density values were expressed as a
percentage of the blank controls. Benznidazole was used
as reference drug.Antileishmanial activity. Amastigotes of L. infantum
(MHOM/ET 67), used to infect primary peritoneal
mouse macrophages, were collected from the spleen of
donor hamsters with an established Leishmania infec-
tion of 6 to 8weeks. After aseptic removal of the spleen,
a number of smear impressions were made on a micro-
scope slide and stained with Giemsa stain to enumerate
the amastigote spleen burden using the Stauber index
(total number of amastigotes =weight of spleen (g) 
number amastigotes/cell  2  108). To purify the
amastigotes, the spleen was grinded in 10mL culture
medium in a tissue grinder; the splenic cell suspension
was transferred in a sterile 15mL centrifugation tube
and centrifuged for 10min at 300 rpm and 4 C to
remove most of the cell debris. The supernatant was
then transferred to a sterile 15mL centrifugation tube
and centrifuged for 10min at 2200 rpm and 4 C; the super-
natant was discarded, and the pellet was re-suspended
in 10mL complete culture medium. After one addi-
tional washing cycle and appropriate dilution, this sus-
pension was used as infection inoculum for the in vitro
macrophage cultures.Phytother. Res. 28: 437–443 (2014)
440 S.I. FALCÃO ET AL.To determine in vitro antileishmanial activity, 3 104
macrophages were seeded in each well of a 96-well
plate. After 48 h outgrowth, 5 104 amastigotes/well
were added and incubated for 2 h at 37 C. Pre-diluted
compounds were subsequently added, and the plates
were further incubated for 120 h at 37 C and 5% CO2.
Parasite burdens were determined microscopically after
Giemsa staining and expressed as a percentage of the
blank controls without propolis sample. Miltefosine
was used as reference drug.
Cytotoxicity assay. MRC-5SV2 human foetal lung ﬁbro-
blasts were cultivated in MEM, supplemented with L-
glutamine (20mM), 16.5mM sodium hydrogen carbonate
and 5% FCS at 37 C and 5% CO2. For the assay, 10
4
MRC-5 cells/well were seeded onto the test plates
containing the pre-diluted compounds and incubated at
37 C and 5% CO2 for 72h. Cell viability was determined
after addition of resazurin. Tamoxifen was used as refer-
ence drug.
Antibacterial and antifungal assays. These assays have
been also performed at the Laboratory of Microbiology,
Parasitology and Hygiene (LMPH), Antwerp Univer-
sity, Belgium (Cos et al., 2006) against Staphylococcus
aureus, Candida albicans, Trichophyton rubrum and
Aspergillus fumigatus. IC50 values were determined
from ﬁve 4-fold dilutions, starting from a maximum
concentration of 64 mg/mL. Ampicillin was used as refer-
ence for S. aureus, while miconazole was used as refer-
ence for Candida, Trichophyton and Aspergillus. The
impact of toxicity was determined by analyzing the
selectivity index (SI), the ratios between the MRC-5SV2
cytotoxic and the antimicrobial IC50 values.
Statistical analysis. For the phenolic composition and
antioxidant activity, the assays were carried out in tripli-
cate and presented in the ﬁgures as mean values with
standard deviation. The results were analyzed using
one-way analysis of variance followed by Tukey’s HSD
test with a = 0.05. The analysis was performed using
SPSS v. 18.0 program. The result of this analysis can
be found in the ﬁgures: samples with the same letter
are statistically no different.
For the antiprotozoal, antibacterial and antifungal
activity, in each experiment, the 50% of microbial
growth (IC50) and human cell growth (CC50) inhibition
value was determined from the concentration–response
curves, and the results were expressed as the mean
standard deviation of two independent experiments.Figure 1. Phenolic composition of propolis and their ethanolic
extracts. A1, North-eastern propolis; A2, Central propolis; PM,
Populus x canadensis male; PF, Populus x canadensis female; C,
Cistus ladanifer. Total phenolics were expressed as caffeic acid:
galangin: pinocembrin (1:1:1) equivalents. Flavones/flavonols were
expressed as galangin equivalents. Flavanones/dihydroflavonols were
expressed aspinocembrin equivalents. In each column,different letters
(a–n) mean significant differences between samples (p<0.05)RESULTS AND DISCUSSION
Propolis is a bee product with a complex chemical com-
position which is largely dependent on its plant origin.
Populus bud exudates and Cistus ladanifer L. leaf
exudates are documented to be potential resin sources
for propolis in Europe (Bankova et al., 2000). In the
present study, these plants were abundant in the hive
neighborhood, and their phenolic content, antioxidantCopyright © 2013 John Wiley & Sons, Ltd.and antimicrobial activities were evaluated and com-
pared to propolis.
Figure 1 shows the content of total phenolic compounds,
ﬂavones/ﬂavonols and ﬂavanones/dihydroﬂavonols in
propolis and in the Cistus and Populus ethanolic extracts.
All values are statistically different. The highest total phe-
nolic content was found in the propolis samples, but there
is no great difference between the two samples of dis-
tinct geographical origin. The total phenolic content of
329mg/g for the central propolis (A2) is in line with
other studies on Portuguese propolis (Moreira et al.,
2008). For the plant extracts, the values ranged from
167 to 278mg/g with the male Populus sample revealing
a higher value than Cistus ladanifer.
For the ﬂavones and ﬂavonols quantiﬁed by the alu-
minium chloride method, a higher content was also
found in propolis compared to the plant extracts.
North-eastern and central propolis samples showed
values ranging from 81 to 97mg/g, while the plant ex-
tracts contained 39 to 47mg/g (Fig. 1). The ﬂavanones
and dihydroﬂavonols quantiﬁed by the DNP method
were present in smaller quantities in the Cistus extract
(113mg/g) compared with propolis andPopulus ethanolic
extracts (Fig. 1).
Phenolic compounds, due to their hydroxyl groups,
are known to act as antioxidants (Rice-Evans et al.,
1996). Therefore, the activity of the extracts was evalu-
ated with the DPPH free radical scavenging method
(Brand-Williams et al., 1995). The EC50 values are shown
in Fig. 2A with all propolis and plant extracts possessing
signiﬁcant free radical scavenging activity. The extracts
of male and female Populus x canadensis bud exudates
exhibited the highest activity with EC50 values of 0.014
and 0.015mg/mL, respectively. These values were close
to the standard mixture of pure compounds used in this
study (caffeic acid: galangin: pinocembrin, 1:1:1), pointing
out the signiﬁcant activity of these natural extracts.
The propolis samples showed an EC50 value around
0.018mg/mL, while Cistus ladanifer resin presented the
lowest scavenging activity (Fig. 2A).Phytother. Res. 28: 437–443 (2014)
Figure 2. Antioxidant activity of propolis and ethanolic plant
extracts (A) against DPPH and (B) reducing power. A1, North-
eastern propolis; A2, Central propolis; PM, Populus x canadensis
male; PF, Populus x canadensis female; C,Cistus ladanifer; S, caffeic
acid: galangin: pinocembrin (1:1:1) used as standard. Reducing
power was expressed as caffeic acid: galangin: pinocembrin (1:1:1)
equivalents. In each column, different letters (a–g) mean significant
differences between samples (p<0.05)
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donating activity, which is an important mechanism for
phenolic antioxidant action (Yildirim et al., 2001). The
reducing power was expressed as caffeic acid: galangin:
pinocembrin (1:1:1) equivalents (Fig. 2B). Once again,
the best activity was found for the male Populus x
canadensis followed by the propolis sample A1 with
values of 807mg/g and 710mg/g respectively. Sample
A2 revealed a very low reduction power, even lower
than the plant extracts.
Considering the above, the highest radical scaveng-
ing ability or reduction power was not found for the
samples with the richer phenolic content, meaning that
the observed bioactivity cannot be judged solely on theTable 1. Antiprotozoal activity against P. falciparum, L. infantum, T. c
Samplea
IC50 mg/mL
P. falciparum L. infantum
A1 30.14.1 8.11.0
A2 8.81.8 8.10.9
PM 10.92.1 8.11.1
PF 28.53.8 8.11.3
C 17.02.5 32.52.7
Chloroquine 0.040.01 -
Miltefosine - 2.40.8
Benznidazole - -
Melarsoprol - -
Tamoxifen
aSamples: A1: North-eastern propolis; A2:Central propolis; PM:Populus x c
Copyright © 2013 John Wiley & Sons, Ltd.basis of the overall phenolic content. In fact, some of
the individual phenolic compounds present in the extract
can play a more important role in the activity than others.
Portuguese propolis phenolic extracts and their potential
plant sources were evaluated for in vitro activity against
the pathogenic protozoa P. falciparum, L. infantum, T.
cruzi andT. brucei (Table 1). To assess selectivity of action,
cytotoxicity against MRC-5 ﬁbroblasts was included.
Activity against P. falciparum was found for the prop-
olis sample from the central region of Portugal with an
IC50 of 8.83 mg/mL, while the phenolic extract of male
Populus showed the highest SI (SI = 4). Filho et al.
(2009) reported an IC50 of 20 mg/mL (SI> 2.4) for
Brazilian green propolis and of 25 mg/mL (SI> 1.9) for
the extract of Baccharis dracunculifolia, the ﬂoral origin
of green propolis. These values are actually in the same
range as our results and in fact reveal that our samples
A2 and PM show a marginally higher antiplasmodial
potential, which may be associated with the richer
composition in ﬂavonoids for propolis from Populus
(Machado et al., 2007). For an antimalarial ‘hit’, the
WHO Special Programme for Research and Training
in Tropical Diseases deﬁnes an activity criterion to be
IC50 <0.2mg/mL with SI >20 (TDR, 2007). Therefore,
the relevance of the antimalarial action of our samples
requires further research. Propolis toxicity was referred
by Marcucci (1995) and Burdock (1998) to be associated
with some of the propolis components, namely caffeic acid
esters present in the European propolis with origin in the
poplar buds. The synergistic effect of all compounds in the
entire extract can be responsible for a real loss of activity,
while the isolated compounds or fractions of it can indeed
reveal a higher activity (Filho et al., 2009).
ForL. infantum, propolis samples and male and female
Populus showed a similar IC50 value of 8.11mg/mL.Cistus
ladanifer showed the lowest activity with an IC50 value of
32.46mg/mL. Duran et al. (2011) reported antileishmanial
activity on two different Turkish propolis samples with
IC50 values ranging between 125 and 325mg/mL. Filho
et al. (2009) presented IC50 values of 49 and 45mg/mL
for a green propolis sample and its plant source B.
dracunculifolia against L. donovani.
Our results for the activity against T. cruzi were very
similar between all the samples tested, ranging from 6.16
to 8.59mg/mL (Table 1). Prytzyk et al. (2003) and Cunha
et al. (2004) tested the activity againstT. cruzi in Bulgarian
and Brazilian propolis whereby all the extracts showed a
lower activity than the Portuguese propolis, with valuesruzi, T. brucei and cytotoxicity in MRC-5 ﬁbroblast cells
(mean sd) -- duplicate testing
T. cruzi T. brucei MRC-5
6.21.9 1.70.5 12.04.3
7.72.1 3.81.2 9.73.5
7.81.8 5.71.3 38.45.8
7.61.6 5.31.9 33.76.2
8.62.0 2.00.4 32.24.5
- - -
- - -
2.50.6 - -
- 0.0050.001 -
10.52.5
anadensismale; PF:Populus x canadensis female; C:Cistus ladanifer.
Phytother. Res. 28: 437–443 (2014)
Table 2. Antimicrobial activity against Staphylococcus aureus,
Candida albicans,Trichophyton rubrum andAspergillus fumigatus
Samplea
IC50 mg/mL (mean sd) -- duplicate testing
S. aureus C. albicans T. rubrum A. fumigatus
A1 24.63.8 32.03.2 14.51.2 >64.0
A2 25.72.9 43.14.1 11.00.9 >64.0
PM >64.0 33.63.5 38.92.3 >64.0
PF >64.0 >64.0 24.22.1 >64.0
C >64.0 >64.0 20.81.8 >64.0
Ampicillin 1.10.3
Miconazole 4.01.4 0.50.1 1.50.8
aSamples: A1: North-eastern propolis; A2: Central propolis; PM:
Populus x canadensis male; PF: Populus x canadensis female; C:
Cistus ladanifer
442 S.I. FALCÃO ET AL.ranging between 108.8 and 1065mg/mL for Bulgarian
propolis and between 421 and 1437mg/mL for Brazilian
propolis. These biological activity variations are likely as-
sociated with different chemical compositions presented
by the different propolis types. No cytotoxicity tests were
performed in that study.
For all antiprotozoal assays, the relatively highest activ-
ities were found against T. brucei. Sample A1 was the
most active with an IC50 value of 1.70mg/mL (Table 1)
which is in the same range as the antitrypanosomal refer-
ence drug suramin (Otoguro et al., 2012). Isolation of phe-
nolic compounds from propolis can signiﬁcantly increase
the activity: b-phenylethyl caffeate showed a high activity
(IC50 = 0.013 mg/mL; SI = 150), while 2,2-dimethylallyl
caffeate exhibited a reduced antitrypanosomal activity
(IC50 = 12.5 mg/mL), demonstrating the potential loss
of activity when testing the entire extract (Otoguro
et al. (2012).
The activity of the propolis and plant ethanolic extracts
was also evaluated against bacteria and fungi (Table 2).
The results reveal that the plant extracts do no exhibit
relevant antimicrobial activity compared to propolis
ethanolic extracts, with exception of T. rubrum. In gen-
eral, both propolis samples revealed a similar antimi-
crobial effect, with the highest activity found against
T. rubrum and the lowest against A. fumigatus. Recently,
Silva et al. (2012) veriﬁed that propolis from the North
and Centre of Portugal was more active against S. aureus
than against C. albicans, which agrees with our results. In
fact, considering that the IC50 value for T. rubrum is even
lower than for S. aureus, it can be considered a promising
result. However, one should also consider the cytotoxic-
ity, which was rather high in our study.
In summary, the present study focused on the screening
of Portuguese propolis samples and two potential plant
sources against pathogenic protozoa, revealing reduced
activity and low selectivity. Since propolis has a complex
chemical composition, an extract fractionation will beCopyright © 2013 John Wiley & Sons, Ltd.needed to identify putative active components. Also,
these results were evaluated according to criteria set
up by the WHO Special Programme for Research and
Training in Tropical Diseases, what should be considered
by future studies with others propolis samples to enable
effective comparisons between scientiﬁc ﬁndings.Acknowledgements
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